There is also evidence to suggest that bevacizumab increases the sensitization of tumor cells to cytotoxic agents (13) and the ability to quantify the effect of bevacizumab on both soluble VEGF and membrane bound VEGF may also help elucidate the mechanisms of this process. Here, VEGFA is linked to neoplasm.